Grifols SA (GIKLY) stock

GIKLYOTCPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GRFS

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 17, 2026Score 9/30

$5.55+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.91BP/E 4.2Yield –

Grifols gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 38.0%, against 38.7% the year before. The highest annual figure on record is 49.8% in fiscal 2017.

Annual gross margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	38.0%	−0.7
FY2024	Dec 31, 2024	38.7%	+1.1
FY2023	Dec 31, 2023	37.7%	+1.2
FY2022	Dec 31, 2022	36.5%	−3.3
FY2021	Dec 31, 2021	39.8%	−2.4
FY2020	Dec 31, 2020	42.2%	−3.7
FY2019	Dec 31, 2019	45.9%	+0.2
FY2018	Dec 31, 2018	45.7%	−4.2
FY2017	Dec 31, 2017	49.8%	+2.6
FY2016	Dec 31, 2016	47.2%	−1.9
FY2015	Dec 31, 2015	49.1%	–

Where these numbers come from

Parsed from the XBRL in Grifols's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jan 4, 2016
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GIKLY.

Compare: GIKLY vs OGN · GIKLY vs TEVA · GIKLY vs VTRS · GIKLY vs ONC · GIKLY vs BHC

Revenue growth4.3% · median 4.4%

Gross margin38.0% · median 58.8%

Operating margin16.5% · median 11.3%

Net margin5.3% · median 4.2%

Company	Revenue	Growth
VTRS	$14.74B	+4.4%
TEVA	$14.10B	-15.2%
BHC	$11.11B	+10.8%
GIKLY	€7.52B	+4.3%
ONC	$6.13B	+34.3%
OGN	$6.10B	-3.2%

Company

Exchange: OTC
Industry: Pharmaceutical Preparations
Employees: 1,613
Auditor: KPMG Auditores, S.L.
SEC CIK: 1438569

Advertisement
300 × 250

See a number that looks wrong?